{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:11:22Z","timestamp":1791972682487,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":502,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1111\/hpb.12450","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T13:45:36Z","timestamp":1436881536000},"page":"691-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":356,"title":["Hilar Cholangiocarcinoma: expert consensus statement"],"prefix":"10.1016","volume":"17","author":[{"given":"John C.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Aloia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nagino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/hpb.12450_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1007302","article-title":"Recent advances in the management of cholangiocarcinomas","volume":"14","author":"Vauthey","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1111\/hpb.12450_bb0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/13651820500372533","article-title":"Hilar cholangiocarcinoma: diagnosis and staging","volume":"7","author":"Jarnagin","year":"2005","journal-title":"HPB"},{"key":"10.1111\/hpb.12450_bb0020","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"de Groen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/hpb.12450_bb0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis","volume":"95","author":"Patel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/hpb.12450_bb0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/hpb.12450_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1148\/radiol.2271010938","article-title":"Case 57: eosinophilic cholangiopathy","volume":"227","author":"Vauthey","year":"2003","journal-title":"Radiology"},{"key":"10.1111\/hpb.12450_bb0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.amjsurg.2006.10.024","article-title":"High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma","volume":"193","author":"Aloia","year":"2007","journal-title":"Am J Surg"},{"key":"10.1111\/hpb.12450_bb0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13651820801992583","article-title":"Positron emission tomography (PET) for cholangiocarcinoma","volume":"10","author":"Breitenstein","year":"2008","journal-title":"HPB"},{"key":"10.1111\/hpb.12450_bb0050","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1600-6143.2006.01358.x","article-title":"How useful is PET\/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation?","volume":"6","author":"McCormack","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/hpb.12450_bb0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"Heimbach","year":"2011","journal-title":"HPB"},{"key":"10.1111\/hpb.12450_bb0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0016-5107(02)70442-2","article-title":"Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1)","volume":"56","author":"De Bellis","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/hpb.12450_bb0065","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.humpath.2007.04.015","article-title":"Fluorescence in\u00a0situ hybridization in diagnostic cytology","volume":"38","author":"Halling","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1111\/hpb.12450_bb0070","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1572-0241.2004.30281.x","article-title":"A comparison of routine cytology and fluorescence in\u00a0situ hybridization for the detection of malignant bile duct strictures","volume":"99","author":"Kipp","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/hpb.12450_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in\u00a0situ hybridization tests in primary sclerosing cholangitis","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/hpb.12450_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9610(91)90361-G","article-title":"Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors)","volume":"161","author":"Wetter","year":"1991","journal-title":"Am J Surg"},{"key":"10.1111\/hpb.12450_bb0085","first-page":"265","article-title":"Klatskin-mimicking lesions: still a diagnostical and therapeutical dilemma?","volume":"58","author":"Juntermanns","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/hpb.12450_bb0090","first-page":"170","article-title":"Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver","volume":"140","author":"Bismuth","year":"1975","journal-title":"Surg Gynecol Obstet"},{"key":"10.1111\/hpb.12450_bb0095","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MOG.0b013e3283292383","article-title":"A conceptual proposal for staging ductal cholangiocarcinoma","volume":"25","author":"Blechacz","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/hpb.12450_bb0105","series-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"key":"10.1111\/hpb.12450_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1245\/s10434-012-2486-0","article-title":"Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma","volume":"20","author":"Juntermanns","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/hpb.12450_bb0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/bjs.6788","article-title":"Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma","volume":"97","author":"Kobayashi","year":"2010","journal-title":"Br J Surg"},{"key":"10.1111\/hpb.12450_bb0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00534-009-0204-5","article-title":"Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience","volume":"17","author":"Lee","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1111\/hpb.12450_bb0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archsurg.139.5.514","article-title":"Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients","volume":"139","author":"Rea","year":"2004","journal-title":"Arch Surg"},{"key":"10.1111\/hpb.12450_bb0130","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00268-007-9001-y","article-title":"Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications","volume":"31","author":"Hasegawa","year":"2007","journal-title":"World J Surg"},{"key":"10.1111\/hpb.12450_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000160701.38945.82","article-title":"Surgical management of hilar cholangiocarcinoma","volume":"241","author":"Hemming","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archsurg.2011.116","article-title":"Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center","volume":"146","author":"Hong","year":"2011","journal-title":"Arch Surg"},{"key":"10.1111\/hpb.12450_bb0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/13651820500373010","article-title":"Surgical management of hilar cholangiocarcinoma: the Nagoya experience","volume":"7","author":"Nishio","year":"2005","journal-title":"HPB"},{"key":"10.1111\/hpb.12450_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archsurg.2011.771","article-title":"Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients","volume":"147","author":"Nuzzo","year":"2012","journal-title":"Arch Surg"},{"key":"10.1111\/hpb.12450_bb0155","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ejso.2012.08.009","article-title":"Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV","volume":"38","author":"Cheng","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/hpb.12450_bb0160","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s00268-012-1497-0","article-title":"Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution","volume":"36","author":"Kow","year":"2012","journal-title":"World J Surg"},{"key":"10.1111\/hpb.12450_bb0165","first-page":"321","article-title":"Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value?","volume":"59","author":"Wahab","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/hpb.12450_bb0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.sla.0000201482.11876.14","article-title":"Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up","volume":"243","author":"Nagino","year":"2006","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0175","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00534-009-0205-4","article-title":"Hilar cholangiocarcinoma: the Memorial Sloan\u2013Kettering Cancer Center experience","volume":"17","author":"Rocha","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1111\/hpb.12450_bb0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1445-2197.2012.06195.x","article-title":"Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre","volume":"83","author":"Song","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1111\/hpb.12450_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.soc.2008.12.007","article-title":"Portal vein embolization in hilar cholangiocarcinoma","volume":"18","author":"Palavecino","year":"2009","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1111\/hpb.12450_bb0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/SLA.0b013e31826f4b0e","article-title":"Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks","volume":"257","author":"Iacono","year":"2013","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/13651820802007472","article-title":"Cholangiocarcinoma: preoperative biliary drainage (Con)","volume":"10","author":"Laurent","year":"2008","journal-title":"HPB"},{"key":"10.1111\/hpb.12450_bb0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/13651820801992666","article-title":"Preoperative biliary drainage before resection for cholangiocarcinoma (Pro)","volume":"10","author":"Nimura","year":"2008","journal-title":"HPB"},{"key":"10.1111\/hpb.12450_bb0215","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00330-007-0796-6","article-title":"Percutaneous drainage and stenting for palliation of malignant bile duct obstruction","volume":"18","author":"van Delden","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1111\/hpb.12450_bb0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4251\/wjgo.v2.i3.146","article-title":"Interventional radiology in the management of malignant biliary obstruction","volume":"2","author":"George","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1111\/hpb.12450_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gie.2008.04.005","article-title":"Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach","volume":"69","author":"Paik","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/hpb.12450_bb0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jvir.2012.09.019","article-title":"Endoscopic or percutaneous biliary drainage for Klatskin tumors?","volume":"24","author":"Walter","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1111\/hpb.12450_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00535-010-0298-1","article-title":"Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma","volume":"46","author":"Kawakami","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1111\/hpb.12450_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/SLA.0b013e318262b2e9","article-title":"Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications","volume":"257","author":"Kawashima","year":"2013","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/hpb.12450_bb0250","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"issue":"Suppl.\u00a02","key":"10.1111\/hpb.12450_bb0255","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/lt.20266","article-title":"Transplantation for hilar cholangiocarcinoma","volume":"10","author":"Heimbach","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/hpb.12450_bb0260","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/lt.20137","article-title":"Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database","volume":"10","author":"Roberts","year":"2004","journal-title":"Liver Transpl"},{"issue":"Suppl.\u00a02","key":"10.1111\/hpb.12450_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/lt.20265","article-title":"When is a patient too well and when is a patient too sick for a liver transplant?","volume":"10","author":"Merion","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/hpb.12450_bb0270","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/hpb.12450_bb0275","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2006.09.033","article-title":"Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival","volume":"33","author":"Cheng","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/hpb.12450_bb0280","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/j.ijrobp.2010.12.019","article-title":"Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer","volume":"81","author":"Kim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/hpb.12450_bb0285","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1067\/msy.2002.127555","article-title":"Improved survival in resected biliary malignancies","volume":"132","author":"Nakeeb","year":"2002","journal-title":"Surgery"},{"key":"10.1111\/hpb.12450_bb0290","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(99)00472-1","article-title":"Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma","volume":"46","author":"Todoroki","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/hpb.12450_bb0295","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1245\/s10434-008-9998-7","article-title":"Extrahepatic bile duct adenocarcinoma: patients at high risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone","volume":"15","author":"Borghero","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/hpb.12450_bb0300","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0360-3016(02)02952-8","article-title":"Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer","volume":"54","author":"Kim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/hpb.12450_bb0305","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0310","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-199506000-00017","article-title":"Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival","volume":"221","author":"Pitt","year":"1995","journal-title":"Ann Surg"},{"key":"10.1111\/hpb.12450_bb0315","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2010.06.018","article-title":"Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma","volume":"81","author":"Ghafoori","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/hpb.12450_bb0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejrad.2007.01.037","article-title":"Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study","volume":"62","author":"V\u00e1lek","year":"2007","journal-title":"Eur J Radiol"},{"key":"10.1111\/hpb.12450_bb0325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cncr.20753","article-title":"Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial","volume":"103","author":"Alberts","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/hpb.12450_bb0330","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study","volume":"15","author":"Andre","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/hpb.12450_bb0335","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.bjc.6601796","article-title":"Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil\/leucovorin for locally advanced or metastatic carcinoma of the biliary tract","volume":"90","author":"Hsu","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1111\/hpb.12450_bb0340","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/annonc\/mdh172","article-title":"Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience","volume":"15","author":"Knox","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/hpb.12450_bb0345","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/annonc\/mdh096","article-title":"Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial","volume":"15","author":"Kornek","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/hpb.12450_bb0350","first-page":"783","article-title":"Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas","volume":"48","author":"Kubicka","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/hpb.12450_bb0355","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1016209901417","article-title":"Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas","volume":"20","author":"Kuhn","year":"2002","journal-title":"Invest New Drugs"},{"key":"10.1111\/hpb.12450_bb0360","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:DRUG.0000011797.09549.53","article-title":"Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer","volume":"22","author":"Tsavaris","year":"2004","journal-title":"Invest New Drugs"},{"key":"10.1111\/hpb.12450_bb0365","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bjc.6605211","article-title":"Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study \u2013 the UK ABC-01 Study","volume":"101","author":"Valle","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1111\/hpb.12450_bb0370","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/hpb.12450_bb0375","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","article-title":"Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial","volume":"15","author":"Malka","year":"2014","journal-title":"Lancet Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15312478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15312478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:01:05Z","timestamp":1761264065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X15312478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1365182X15312478"],"URL":"https:\/\/doi.org\/10.1111\/hpb.12450","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hilar Cholangiocarcinoma: expert consensus statement","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/hpb.12450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}